The World Health Organization (WHO) has reported a significant surge in mpox cases across Africa, with over 1,500 new infections confirmed since December 1, 2024. This uptick highlights the disease’s ongoing threat, particularly in regions such as the Democratic Republic of Congo (DRC), which has reported the highest incidence rates.
Mpox, a viral disease primarily found in central and western Africa near tropical forests, has been a persistent health challenge since it was first recorded in humans in the DRC in 1970. Over the past year, 12 African countries have reported active outbreaks, with alarming statistics revealing the widespread impact of the disease.
Alarming Statistics
From January 1, 2024, to January 5, 2025, Africa documented 14,700 confirmed mpox cases and 66 deaths, according to the WHO. These figures mark an increase of 1,529 cases and nine deaths since December 1, 2024. The hardest-hit countries include:
- DRC: 2,464 cases since November 25, 2024
- Burundi: 798 cases
- Uganda: 767 cases
- Rwanda: 17 cases
- Kenya: 12 cases
Globally, from January 2022 to November 2024, over 117,663 mpox cases and 263 fatalities have been reported across 127 countries.
Global Health Emergency Reinstated
The WHO initially declared mpox a global health emergency from July 2022 to May 11, 2023, when declining cases led to its suspension. However, with Africa experiencing a resurgence, the emergency status was reinstated on August 14, 2024, emphasizing the urgent need for intensified response efforts.
Vaccination Campaigns
To combat the outbreak, countries like Nigeria have launched targeted vaccination campaigns. These efforts prioritize healthcare workers and individuals with weakened immune systems, aiming to curb transmission and protect vulnerable populations.
The resurgence of mpox in Africa serves as a stark reminder of the region’s vulnerability to infectious diseases and underscores the importance of sustained global and regional collaboration to manage outbreaks effectively.
